Sfoglia per Rivista HAEMATOLOGICA
K-CL co-transport plays an important role in normal and ß thalassemic erythropoiesis
2007 L. De Franceschi, L. Ronzoni, M.D. Cappellini, F. Cimmino, A. Siciliano, S.L. Alper, V. Servedio, C. Pozzobon, A. Iolascon
Key concepts and critical issues on epoetin and filgrastim biosimilars: a position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation
2011 G. Barosi, A. Bosi, M.P. Abbracchio, R. Danesi, A. Genazzani, P. Corradini, F. Pane, S. Tura
KIT activating mutations : incidence in adult and pediatric AML, and identification of an internal tandem duplication
2004 A. Beghini, C.B. Ripamonti, R. Cairoli, G. Cazzaniga, P. Colapietro, F. Elice, G. Nadali, G. Grillo, O.A. Haas, A. Biondi, E. Morra, L. Larizza
Kreuth V initiative: European consensus proposals for treatment of haemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies
2020 F. Peyvandi, K. Berger, R. Seitz, A. Hilger, M. Hecquet, M. Wierer, K. Buchheit, B. O Mahony, A. Bok, M. Makris, U. Mansmann, W. Schramm, P.M. Mannucci
Labile plasma iron levels in heavily iron-overloaded patients with transfusion-dependent anaemias in response to deferasirox therapy : results from the large-scale, prospective 1-year EPIC trial
2009 A. Kattamis, A. El Beshlawy, J.F. Seymour, C.K. Li, H. Nick, D. Habr, G. Domokos, B. Roubert, M.D. Cappellini
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia
2019 J.A. Cohen, F.M. Rossi, A. Zucchetto, R. Bomben, L. Terzi-di-Bergamo, K.G. Rabe, M. Degan, A. Steffan, J. Polesel, E. Santinelli, I. Innocenti, G. Cutrona, G. D' Arena, G. Pozzato, F. Zaja, A. Chiarenza, D. Rossi, F. Di Raimondo, L. Laurenti, M. Gentile, F. Morabito, A. Neri, M. Ferrarini, C.D. Fegan, C.J. Pepper, G. Del Poeta, S.A. Parikh, N.E. Kay, V. Gattei
Lenalidomide plus low dose dexamethasone as first line therapy in patients with primary plasma cell leukemia : planned interim analysis of a pilot study from the gimema-italian myeloma network
2010 P. Musto, F. D'Auria, M.T. Petrucci, F. Morabito, F. Nobile, M. Offidani, F. Di Raimondo, A. Falcone, R. Lerose, E. Zifarone, A. Zonno, V. Callea, A. Levi, C. Mazzone, G. Pietrantuono, M.C. Martorelli, O. Villani, R. Guariglia, G.R. Mansueto, V. Grieco, G. Bianchino, A. Neri, K. Todoerti, P. Omedè, S. Bringhen, M. Cavo, M. Boccadoro, A. Palumbo
Lenalidomide, melophalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma
2008 A. Palumbo, P. Falco, G. Sanpaolo, A. Falcone, V. Ferderico, I. Canepa, M. Crugnola, L. Baldini, S. Caltagirone, A. Larocca, F. Gay, V. Magarotto, M.T. Petrucci, M. Boccadoro
Lessons from very severe, refractory and fatal primary autoimmune haemolytic anaemias
2015 W. Barcellini, B. Fattizzo, A. Zaninoni, F. Nesa, A. Zanella, A. Cortelezzi
Leucocytosis is a risk factor for recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia
2009 V. De Stefano, T. Za, E. Rossi, A.M. Vannucchi, M. Ruggeri, E. Elli, C. Micò, A. Tieghi, R. Cacciola, C. Santoro, G. Gerli, N. Vianelli, P. Guglielmelli, L. Pieri, F. Scognamiglio, F. Rodeghiero, E.M. Pogliani, G. Finazzi, L. Gugliotta, G. Leone, T. Barbui
Leukocyte counts in professional football players
2003 A. Dolci, G. Nanni, G. Sisca, B. Costantino, A. Baldari, G. Palaia, G. Banfi
Leukocytosis is a risk factor for recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia
2009 V. De Stefano, T. Za, E. Rossi, A.M. Vannucchi, M. Ruggeri, E. Elli, C. Micò, A. Tieghi, R.R. Cacciola, C. Santoro, G. Gerli, N. Vianelli, P. Guglielmelli, L. Pieri, F. Scognamiglio, F. Rodeghiero, E.M. Pogliani, G. Finazzi, L. Gugliotta, G. Leone, T. Barbui
Levels of coagulation factors and venous thromboembolism
2003 A. Tripodi
Lipid peroxidation and inflammatory status during TKI treatment in chronic myeloid leukemia patients: interim analysis of a prospective multicenter study
2017 A. Sicuranza, L. Aprile, E. Abruzzese, A. Iurlo, S. Galimberti, A. Gozzini, N. Sgherza, L. Puccetti, G. Papini, D. Cattaneo, F. Stagno, F. Di Raimondo, G. Specchia, U. Occhini, R. Lemoli, M. Breccia, L. Luciano, A. Bosi, M. Petrini, M. Bocchia
Liver fibrosis in adult thalassemia patients assessed by transient elastography
2008 E. Cassinerio, M. Fraquelli, M. Fasulo, C. Cesaretti, P. Pattoneri, C. Rigamonti, D. Conte, M.D. Cappellini
Liver iron concentration and morbidity in patients with thalassemia intermedia
2011 K. Musallam, J. Wood, M.D. Cappellini, I. Motta, H. Tamim, A. Taher
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma
2019 E. Taiana, D. Ronchetti, V. Favasuli, K. Todoerti, M. Manzoni, N. Amodio, P. Tassone, L. Agnelli, A. Neri
Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemia
1996 M. Ladetto, P. Corradini, M. Astolfi, S. Campana, C. Tarella, A. Pileri
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second-and third-generation tyrosine kinase inhibitors
2019 G. Caocci, O. Mulas, M. Annunziata, L. Luciano, E. Abruzzese, M. Bonifacio, E.M. Orlandi, F. Albano, S. Galimberti, A. Iurlo, P. Pregno, N. Sgherza, B. Martino, G. Binotto, F. Castagnetti, A. Gozzini, M. Bocchia, C. Fozza, F. Stagno, M.P. Simula, F. De Gregorio, M. Trawinska, L. Scaffidi, C. Elena, I. Attolico, C. Baratè, D. Cattaneo, F. Pirillo, G. Gugliotta, A. Sicuranza, M. Molica, G. La Nasa, R. Foà, M. Breccia
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
2020 S. Riva, I. Mancini, A. Maino, B. Ferrari, A. Artoni, P. Agosti, F. Peyvandi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile